Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice. - Wikidata - awgldk - TriplyDB

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.

http://www.wikidata.org/entity/Q37745980

about

Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.

P2860

Q54939538-AF84B351-DC6B-40C5-A2CB-F9AE0CE7428D

P2860

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.

http://www.wikidata.org/entity/Q37745980

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@en

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@nl

type

label

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@en

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@nl

prefLabel

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@en

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@nl

P1433

Q37745980-1553EFAD-01D3-4B10-BE3C-6B0B8F5D7340

P1476

Q37745980-08A62CC1-7A96-4E92-A764-2DD70EBA9D57

P2093

Q37745980-1F8A5FF0-5B48-4BF7-8251-9B17BC9AB617

Q37745980-4782223B-1A61-46AD-8126-2C966B14A2A4

Q37745980-C163CB4E-0526-48B4-9E33-79F26ED14DD7

Q37745980-E0C7DB94-2B72-466F-965F-D8D0E86A6720

P2860

Q37745980-001741B0-1C17-46F7-A272-1411DFDC5641

Q37745980-0109B0C2-08F1-4E64-826D-87EF22819A1D

Q37745980-02C15EAD-DA17-4B2F-948B-F3A7CEEAD22F

Q37745980-039A6BB2-98FF-4392-BF8D-8F7CD249D10D

Q37745980-187AF37E-D05C-42FC-B486-BA83B0C3B225

Q37745980-1E232575-61C3-41A5-BD3D-7CBE16393F34

Q37745980-1EDFDBEB-39F4-4158-8A28-F5A0B2C0CD73

Q37745980-24C010CE-BD10-417D-BD65-DAAD67002770

Q37745980-264D3707-B269-4475-92CC-2E1875431656

Q37745980-269DA3DC-6F22-4E4C-B293-8B55CB3052AE

P304

Q37745980-0F448907-46A0-41AF-AF8B-354BB66DA28B

P31

Q37745980-B50C238D-AE25-4A2F-A0BF-8AD6A254F0DE

P356

Q37745980-515709D7-9F9E-4DD0-AD90-ECA4F89DE52A

P407

Q37745980-0B7F7A16-7EA6-4E56-B467-72993F3B8BBD

P433

Q37745980-40DEB125-1BBB-4074-9142-29B33606CC84

P478

Q37745980-A590B9CE-951C-4780-BC77-436F3EAB2395

P50

Q37745980-94958BE3-EA25-4C30-A70B-AC97EF4F328E

P577

Q37745980-B33B9FB9-E253-4FDB-99B5-55567593BE80

P698

Q37745980-98849B30-3B4D-437A-B97C-5C2962A440B1

P921

Q37745980-50CFAD0E-F9DD-4232-B366-ACF56563CCDC

Q37745980-DBBD192F-49F0-4226-A011-0C931E2986B0

P932

Q37745980-E5391EC3-4192-4106-8E90-4F5FE0760B79

P356

ONCOTARGET.13770

P1433

P1476

Novel Epstein-Barr virus-like ...... l responses in immunized mice.

@en

P2093

Elizabeth M Perez

http://www.w3.org/2001/XMLSchema#string

Joslyn Foley

http://www.w3.org/2001/XMLSchema#string

Rute Silva

http://www.w3.org/2001/XMLSchema#string

Timelia Tison

http://www.w3.org/2001/XMLSchema#string

P2860

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination

Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins

Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.

Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect

Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.

P304

19255-19273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13770

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Javier Gordon Ogembo

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27926486

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

5386682

http://www.w3.org/2001/XMLSchema#string